ONCASPAR subst sèche 3750 UI flac
7680669340018
CH-66934
L01XX24
07.16.1.
Reimbursement limitations:
ONCASPAR
Oncaspar est indiqué en association à d’autres agents antinéoplasiques pour le traitement de la leucémie …
1 / 3
google
Details
- Product number
- 6693401
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- pegaspargasum 3750 U.I., saccharum, natrii dihydrogenophosphas anhydricus, dinatrii phosphas, natrii chloridum, pro vitro.
Articles (1)
Oncaspar 750 UI/ml, poudre pour solution injectable
poudre pour solution injectable
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
3750.0 UI | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 1765.30
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/10/2019
Authorization holder
Servier (Suisse) SA
1202 Genève
Authorization information
- Swissmedic authorization number
- 66934
- Drug name
- Oncaspar, poudre pour solution injectable
- Galenic form
- PULPA
- ATC Code
- L01XX24
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 10/12/2018
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ONCASPAR subst sèche 3750 UI flac
- Description (DE)
- ONCASPAR Trockensub 3750 IE Durchstf
- Market launch
- 10/12/2018
- Narcotic (BTM)
- No